Compare TGTX & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | FSS |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.6B |
| IPO Year | 2008 | 1994 |
| Metric | TGTX | FSS |
|---|---|---|
| Price | $38.65 | $112.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $49.80 | ★ $131.75 |
| AVG Volume (30 Days) | ★ 2.1M | 375.8K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.46% |
| EPS Growth | ★ 1746.67 | 14.57 |
| EPS | 0.12 | ★ 1.14 |
| Revenue | $2,785,000.00 | ★ $2,180,500,000.00 |
| Revenue This Year | $49.08 | $20.94 |
| Revenue Next Year | $26.69 | $6.79 |
| P/E Ratio | $326.42 | ★ $97.54 |
| Revenue Growth | N/A | ★ 17.14 |
| 52 Week Low | $25.37 | $92.48 |
| 52 Week High | $44.65 | $132.89 |
| Indicator | TGTX | FSS |
|---|---|---|
| Relative Strength Index (RSI) | 52.03 | 46.24 |
| Support Level | $33.05 | $106.30 |
| Resistance Level | $44.65 | $114.41 |
| Average True Range (ATR) | 1.90 | 3.23 |
| MACD | -0.42 | -0.90 |
| Stochastic Oscillator | 38.19 | 20.80 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, it has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. Its pipeline includes UBLITUXIMAB, SUB-Q UBLITUXIMAB, and AZER-CEL. Geographically, it generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from the international market.
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.